• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

治疗甲真菌病的方法。

Therapies for the treatment of onychomycosis.

机构信息

Department of Medicine, University of Toronto School of Medicine, Toronto, Ontario, Canada; Mediprobe Research, Inc., London, Ontario, Canada.

出版信息

Clin Dermatol. 2013 Sep-Oct;31(5):544-54. doi: 10.1016/j.clindermatol.2013.06.011.

DOI:10.1016/j.clindermatol.2013.06.011
PMID:24079583
Abstract

Onychomycosis treatments include nail avulsion and debridement by chemical or surgical procedures, topical and oral antifungals, and device-based therapies. The advantages, disadvantages, and limitations of the different types of treatments--including the most commonly prescribed topical (ciclopirox) and oral (terbinafine, itraconazole, and fluconazole) treatments for onychomycosis caused by dermatophytes, non-dermatophyte molds, and yeasts--are reviewed. Safety and efficacy data for the healthy adult population and for special populations such as children and diabetic patients have confirmed the importance of proper mycological diagnosis before the initiation of therapy as well as the evaluation of the risks and benefits of the different treatments.

摘要

甲真菌病的治疗方法包括拔甲和化学或手术清创、局部和口服抗真菌药物以及器械治疗。本文回顾了不同类型治疗方法的优缺点和局限性,包括最常开处方的治疗皮肤癣菌、非皮肤癣菌霉菌和酵母菌所致甲真菌病的局部药物(环吡酮)和口服药物(特比萘芬、伊曲康唑和氟康唑)。健康成年人以及儿童和糖尿病患者等特殊人群的安全性和疗效数据证实,在开始治疗前进行正确的真菌学诊断以及评估不同治疗方法的风险和益处非常重要。

相似文献

1
Therapies for the treatment of onychomycosis.治疗甲真菌病的方法。
Clin Dermatol. 2013 Sep-Oct;31(5):544-54. doi: 10.1016/j.clindermatol.2013.06.011.
2
Toenail onychomycosis: current and future treatment options.趾甲甲癣:当前及未来的治疗选择
Dermatol Ther. 2007 Jan-Feb;20(1):31-46. doi: 10.1111/j.1529-8019.2007.00109.x.
3
Onychomycosis.甲真菌病。
Clin Dermatol. 2010 Mar 4;28(2):151-9. doi: 10.1016/j.clindermatol.2009.12.006.
4
Pharmacoeconomic analysis of ciclopirox nail lacquer solution 8% and the new oral antifungal agents used to treat dermatophyte toe onychomycosis in the United States.8%环吡酮甲涂剂溶液与美国用于治疗皮肤癣菌性足趾甲真菌病的新型口服抗真菌药物的药物经济学分析。
J Am Acad Dermatol. 2000 Oct;43(4 Suppl):S81-95. doi: 10.1067/mjd.2000.109069.
5
Antifungal Drugs for Onychomycosis: Efficacy, Safety, and Mechanisms of Action.用于甲癣的抗真菌药物:疗效、安全性及作用机制
Semin Cutan Med Surg. 2016 Mar;35(3 Suppl 3):S51-5. doi: 10.12788/j.sder.2016.009.
6
[Onychomycosis].[甲癣]
Hautarzt. 2004 Feb;55(2):143-9. doi: 10.1007/s00105-003-0680-5.
7
An open randomized comparative study to test the efficacy and safety of oral terbinafine pulse as a monotherapy and in combination with topical ciclopirox olamine 8% or topical amorolfine hydrochloride 5% in the treatment of onychomycosis.一项开放性随机对照研究,旨在测试口服特比萘芬脉冲疗法单药治疗以及联合8%环吡酮胺外用制剂或5%盐酸阿莫罗芬外用制剂治疗甲真菌病的疗效和安全性。
Indian J Dermatol Venereol Leprol. 2007 Nov-Dec;73(6):393-6. doi: 10.4103/0378-6323.37056.
8
Topical and surgical treatment of onychomycosis.甲癣的局部及手术治疗。
J Am Acad Dermatol. 1994 Sep;31(3 Pt 2):S74-7. doi: 10.1016/s0190-9622(08)81273-x.
9
Oral treatment options for onychomycosis.甲癣的口服治疗选择。
J Am Podiatr Med Assoc. 1997 Nov;87(11):520-31. doi: 10.7547/87507315-87-11-520.
10
Management of toenail onychomycosis.趾甲甲真菌病的管理
Am J Health Syst Pharm. 1999 May 1;56(9):865-71. doi: 10.1093/ajhp/56.9.865.

引用本文的文献

1
Nail Avulsion: Update with Technical Tips for Successful Outcomes.指甲撕脱术:成功治疗的技术要点更新
Skin Appendage Disord. 2024 Dec;10(6):479-489. doi: 10.1159/000539588. Epub 2024 Jun 28.
2
Penetration Profile of Terbinafine Compared to Amorolfine in Mycotic Human Toenails Quantified by Matrix-Assisted Laser Desorption Ionization-Fourier Transform Ion Cyclotron Resonance Imaging.通过基质辅助激光解吸电离-傅里叶变换离子回旋共振成像定量分析特比萘芬与阿莫罗芬在人类真菌性趾甲中的渗透情况对比
Infect Dis Ther. 2024 Jun;13(6):1281-1290. doi: 10.1007/s40121-024-00979-2. Epub 2024 May 7.
3
Screening sensibility and antifungal activity after topical application of a synthetic lactoferrin-derived antimicrobial peptide.
合成乳铁蛋白衍生抗菌肽局部应用后的筛选敏感性和抗真菌活性。
Am J Transl Res. 2024 Feb 15;16(2):669-680. doi: 10.62347/TCOY1289. eCollection 2024.
4
Membranolytic Activity Profile of Nonyl 3,4-Dihydroxybenzoate: A New Anti-Biofilm Compound for the Treatment of Dermatophytosis.壬基3,4-二羟基苯甲酸酯的膜溶解活性概况:一种用于治疗皮肤癣菌病的新型抗生物膜化合物。
Pharmaceutics. 2023 May 4;15(5):1402. doi: 10.3390/pharmaceutics15051402.
5
Augmenting Azoles with Drug Synergy to Expand the Antifungal Toolbox.通过药物协同作用增强唑类药物以扩充抗真菌药库。
Pharmaceuticals (Basel). 2022 Apr 14;15(4):482. doi: 10.3390/ph15040482.
6
The Success of Topical Treatment of Onychomycosis Seems to Be Influenced by Fungal Features.甲癣局部治疗的成功似乎受真菌特性影响。
Evid Based Complement Alternat Med. 2021 Jul 9;2021:5553634. doi: 10.1155/2021/5553634. eCollection 2021.
7
Polishing the Therapy of Onychomycosis Induced by spp.: Amphotericin B-Loaded Nail Lacquer.优化由 spp. 引起的甲真菌病的治疗方法:载有两性霉素B的指甲油。 (注:原文中“spp.”表述不完整,可能影响对完整意思的理解)
Pharmaceutics. 2021 May 24;13(6):784. doi: 10.3390/pharmaceutics13060784.
8
Incorporation of Nonyl 3,4-Dihydroxybenzoate Into Nanostructured Lipid Systems: Effective Alternative for Maintaining Anti-Dermatophytic and Antibiofilm Activities and Reducing Toxicity at High Concentrations.将壬基3,4 - 二羟基苯甲酸酯掺入纳米结构脂质体系:维持抗皮肤癣菌和抗生物膜活性以及降低高浓度下毒性的有效替代方法。
Front Microbiol. 2020 Jun 5;11:1154. doi: 10.3389/fmicb.2020.01154. eCollection 2020.
9
Topical and device-based treatments for fungal infections of the toenails.用于治疗趾甲真菌感染的局部和基于器械的疗法。
Cochrane Database Syst Rev. 2020 Jan 16;1(1):CD012093. doi: 10.1002/14651858.CD012093.pub2.
10
Recent Patents on Permeation Enhancers for Drug Delivery Through Nails.近期关于通过指甲进行药物递送的渗透促进剂的专利
Recent Pat Drug Deliv Formul. 2019;13(3):203-218. doi: 10.2174/1872211313666191030155837.